942
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Is Acid Phosphatase (PAP) Still Justified in the Management of Prostatic Cancer?

Pages 169-170 | Accepted 22 Sep 1990, Published online: 08 Jul 2009
 

Abstract

The usefulness of acid phosphatase (PAP) and prostate specific antigen (PSA) is compared. the author concludes that PSA is more sensitive, has better organ specificity, does less diurnal variations and correlates better with tumor which makes PSA superior for staging and monitoring of therapy in prostate cancer.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.